Navigation Links
Fewer Breast Cancer Patients to Get Chemo

What is the treatment of choice for all breast cancer patients Chemotherapy Wrong.

Blasting women with toxic chemicals has so far been considered the best way to save their lives.// The bigger the cancer or the more it’s spread, more the poison pumped into the veins of women to kill it. But this approach has undergone a sea change in 2004.

According to guidelines recently adopted in Europe unveiled this weekend at a conference in Texas, very few women with breast cancer get chemotherapy in future. The new approach calls for choosing a treatment based on each woman's particular type of tumor.

So far all decisions were being made on the size of the tumor and the involvement of the lymph nodes. The treatment differed according to the amount of cancer one had. Under the new rules, hormone status — whether a tumor's growth depends on estrogen or progesterone — becomes the single most important factor in picking treatment. The approach here would be more a hormone blocker rather than chemotherapy.

Women have reason to dread chemotherapy. Chemo is a sledgehammer that comes down heavily on all rapidly dividing cells—whether they are out-of-control cancerous cells or healthy ones that naturally grow quickly, like those lining the mouth and stomach. That is why chemotherapy causes hair loss, nausea and mouth sores.

But the worst part is that chemotherapy helps only about 15 percent of breast cancer patients after the usual surgery to remove their tumors. Roughly 25 percent of them get worse despite receiving chemotherapy. More shocking, as many as 60 percent of them would have been fine with hormones alone.

'It is not to say that chemotherapy is no value. It is just to say that the value is smaller in women with hormone-driven disease,' said Dr. Robert Carlson, a Stanford University physician who led the U.S. guideline-writing group. The question now is to determine whether the benefit is so small that onco
'"/>




Page: 1 2 3

Related medicine news :

1. Chemotherapy Pill Has Fewer Side Effects Than IV
2. Fewer teeth & Increased Ischemic Stroke risk
3. Heart Patients More At Risk Get Fewer Medicines
4. Fewer People Die Due To Cancer
5. Fewer Blacks Undergo Lung Cancer Surgery
6. Thailand had Fewer AIDS-Related Deaths, New HIV Cases In 2005
7. Women With Fewer Periods Have Low Risk Of Gynecological Cancer
8. Fewer Doctors Treating For Free
9. Fruits & Vegetables Makes You Look Younger With Fewer Wrinkles
10. Forearm Support Promises Fewer on the Job Injury for Computer Professionals
11. Stronger Doses Fewer Administration for Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Fewer Breast Cancer Patients Get Chemo

(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2
...c Sydney Opera House was added to the list of Worl...truction of Danish architect Jorn Utzon's vision w...w cultural sites given the coveted status by UNESC...ittee, meeting in Christchurch, New Zealand. The ...
...ta, who plays the role of a woman in movie 'Hairsp...him lose weight. The star admits that having to... female character Edna Turnblad in the 2007 remake...turned-movie was the perfect combination to shed t...
...x-girlfriend Kate Middleton's curvaceous figure ha...ays been in style for her slender but athletic fig...In her recent appearances Kate appeared painfully ...y and almost flat chested. And according to specu...
...ent A.P.J. Abdul Kalam Friday called for taking ad...iagnostic tool and of tele-radiology to help the n...e was speaking during a visit to the digital radio...on of India Limited (ECIL), which is working towar...
Other Medicine News:
(Date:9/4/2008)...RICH, Switzerland, September 4 /- Axe...trial to assess the safety and tolerability,of a n...vere pulmonary,infection in cystic fibrosis patien...apeutic agent to be delivered directly to the site...pare the effects of two,different doses of the new...
(Date:9/4/2008)...mg cohort demonstrates potent antiviral activity a...profile -, CAMBRIDGE, Mass., Sept. 4 /PRNewswire-...: IDIX ), a biopharmaceutical company engaged,in ...atment of human viral,and other infectious disease...-of-concept study evaluating IDX899, a non-nucleos...
(Date:9/4/2008)...a Announcements Remain on Schedule with Two Abstra...cal Data Release in November 2008, BRIDGEWATER, N...als,Inc., a specialty pharmaceutical company focu...ic disease, today announced the appointment of,Pet...rectors., Peter Garrambone,s career includes more...
(Date:9/3/2008)... says: Wrong Question Asked. Wrong Children Studie... /PRNewswire-USNewswire/ -- A Centers for Disease,...claims there is no link,between the MMR vaccine an...ys this study does nothing to dispel the growing p... raises several questions concerning design,and me...
Breaking Medicine Technology:Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2CDC Misses Target With Flawed MMR/Autism Study 2Programmed death boosts business 3232 1Programmed death boosts business 3232 2Genomic Health to Present at Bank of America 2008 Healthcare Conference and 7th Annual JMP Securities Research Conference 18761 1Genomic Health to Present at Bank of America 2008 Healthcare Conference and 7th Annual JMP Securities Research Conference 18761 2VIA Pharmaceuticals to Present at Rodman 26 Renshaw 5th Annual Global Healthcare Conference 5223 1Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine 28R 29 28VNP40101M 29 in Combination with Cytarabine 2011 1Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine 28R 29 28VNP40101M 29 in Combination with Cytarabine 2011 2Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine 28R 29 28VNP40101M 29 in Combination with Cytarabine 2011 3
...E)--Jun 20, 2007 - Materia, Inc., a,catalyst techn...s,metathesis platform to Eisai Co., Ltd., a leadin... discovery and development.,The non-exclusive lice..., and patent pharmaceutical compounds and related ...ated intellectual property., Metathesis catalysts ...
...ewswire-USNewswire/ -- The,following statement may...n for the Advancement of Medical Research (CAMR): ...sident Bush once,again used the stroke of his veto...ific and medical research, as well as endanger,the...le. His,executive order directing NIH to continue ...
Other Medicine Technology:Materia Licenses Metathesis Catalyst Platform to Eisai 2President Bush Ignores America's Plea for Support of Stem Cell,Research 2
Rhoton Curettes, titanium, length 191 mm, straight.
Castroviejo "HM" Micro Needle Holder with Tungsten-Carbide Inserts, with catch. Serrated.
Clinical micro clamps by Acland. Matte finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface.
Clinical micro clamps by Acland. Matte finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface.
Medicine Products: